The LIBRA-NET trial, sponsored by the Slovak Academy of Sciences, is positioned within the growing market for non-pharmacological interventions aimed at addressing the rising incidence of dementia, particularly Alzheimer's disease. With an increasing focus on lifestyle modifications as adjunct therapies, this study may provide valuable insights into the efficacy of combined aerobic-strength training and nutritional counseling versus cognitive training. Should the trial demonstrate significant benefits, it could enhance the competitive landscape for lifestyle-based interventions, potentially influencing future treatment guidelines and patient management strategies. The results may also attract interest from stakeholders in the health and wellness sectors, including fitness and nutritional companies, as well as pharmaceutical firms exploring complementary approaches to cognitive health.